Jasper Therapeutics to Present Data on JSP191 Conditioning in SCID patients at the…
JSP191 is well tolerated with no treatment-related adverse events in dose-escalation studySingle-agent conditioning with JSP191 is associated with engraftment, immune reconstitution, and…